FRPT Stock Recent News
FRPT LATEST HEADLINES
Which is the better buy between these two pet stocks?
FRPT reaches a key milestone, marking its 25th consecutive quarter of more than 25% year-on-year net sales growth.
Freshpet (FRPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
This long-term compounder just keeps rolling.
Freshpet, Inc. (NASDAQ:FRPT ) Q3 2024 Earnings Conference Call November 4, 2024 8:00 AM ET Company Participants Jeff Sonnek - Managing Director, Investor Relations, ICR Billy Cyr - Chief Executive Officer Todd Cunfer - Chief Financial Officer Scott Morris - President and Co-Founder Conference Call Participants Mark Astrachan - Stifel Ken Goldman - JPMorgan Rupesh Parikh - Oppenheimer Robert Moskow - TD Cowen Brian Holland - D.A. Davidson Bryan Spillane - Bank of America Jon Anderson - William Blair Peter Benedict - Baird Thomas Palmer - Citi Michael Lavery - Piper Sandler Jim Salera - Stephens Kaumil Gajrawala - Jefferies Marc Torrente - Wells Fargo John Lawrence - The Benchmark Company Operator Greetings.
Here is how Freshpet (FRPT) and Philip Morris (PM) have performed compared to their sector so far this year.
Freshpet (FRPT) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to loss of $0.15 per share a year ago.
Sales rose more than 25% for a 25th straight quarter
25th Consecutive Quarter of >25% Year on Year Net Sales Growth Strong Operating Performance Drove Significant Margin Expansion & Cash Generation Company Raises 2024 Net Sales and Adjusted EBITDA Guidance
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.